2.1 Respiratory Flashcards

1
Q

Define perfusion

A

Blood flow throughout the lungs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define defusion

A

Gas exchange

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What does the upper respiratory system do?

A

Function:
cleansing, filtering, humidifying and warming inhaled air

Nose/sinuses:
nostrils separated by nasal septum
sinuses lighten skull, assist speech
produce mucus that drains to nasal cavities to help trap debris

Pharynx:
nasopharynx: passageway only for air
oropharynx: part of the pharynx that lies between the soft palate and the hyoid bone
Laryngopharynx: where both food and air pass

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Upper respiratory system

Larynx

A

Larynx:
provides airway
routes air, food
contains vocal cords

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Upper respiratory system

Trachea

A

Trachea:
seromucous glands that produce thick mucus
either swallowed or coughed out through mouth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

The lower respiratory system

Lungs

A

Lungs:
elastic connective tissue called stroma
left lung smaller with two lobes
right lung larger with three lobes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

The lower respiratory system

Pleura

A

Pleura:

pleural fluid allows lungs to move over thoracic wall during breathing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

The lower respiratory system

Bronchi and Alveoli

A

Bronchi (larger) and Alveoli (smaller):

respiratory membrane where gas exchange

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

The lower respiratory system

Rib cage and Intercostal muscles

A

Rib cage and intercostal muscles:
Protect lungs
Sternum: manubrium, body and xiphoid process

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Factors affecting respiration
Oxygen, carbon dioxide, hydrogen ion concentrations
Controlled by?

A

Oxygen, carbon dioxide, hydrogen ion concentrations:
Controlled by:
Respiratory centers of the medulla oblongata, pons of brain
Chemoreception in medulla and carotid, aortic bodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Factors affecting respiration

Airway resistance, lung compliance, elasticity?

A

Airway resistance, lung compliance, elasticity?
Distensibility of lungs
Essential in inspiration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Factors affecting respiration

Alveolar surface tention?

A

Alveolar surface tension:
Surfactant
Lipoprotein interferes with adhesiveness of water molecules
Helps expand lungs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Factors affecting respiration

Respiratory volume and capacity:

A

Respiratory volume and capacity:
Pulmonary function test
-total lung capacity (TLC): max inflation
-vital compacity: total amount of air that can be exhaled after max inspiration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Factors affecting respiration

Air pressure

A

Air pressure:

  • inspiration: diaphragm contracting
  • expiration: passive, diaphragm relaxes
  • intrapulmonary pressure: measured inside the alveoli
  • intrapleural pressure: within pleural space
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Respiratory assessments

thoracic

A
Thoracic:
Respiratory rate (12-20 bpm)
Anteroposterior diameter/transverse diameter ratio
Intercostal retraction or bulging
Chest expansion
Trachea position
Lung sounds
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Respiratory assessments

Health interview

A
Health interview:
Current manifestations: onset, characteristics course, severity, precipitating, relieving factors
History of respiratory or lung conditions
Present health status
Medical history
Family history
Risk factors
Lifestyle questions:
-smoking
-environmental exposures
-occupational exposures
-exercise
-recreational drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Respiratory assessment

Nasal and sinus assessment

A
Nasal:
Size
Shape
Color
Nasal cavity health
Ability to smell

Sinus:
No pain during palpitation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Breath sounds

A

Breath sound assessment:
Auscultation
Sounds
Crackles: short, discrete, crackling, bubbling (pneumonia, bronchitis, CHF)
Wheezes : continuous, musical sounds ( bronchitis, emphysema, asthma
Friction rubs: loud, dry, creaking sounds (pleural inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Where are vesicular lung sounds heard?

A

Peripheries of lungs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Where are bronchiolar vascular sounds heard?

A

Over the bronchi
Each side of sternum
Back between scapula

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Where are bronchiolar sounds heard

A

Closer to the throat, near the manubrium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Diagnostic tests

A

Sputum: gram stain, C&S, Cytology, acid-fast bacilli (AFB), detect bacterial infections in lungs. collected in A.M.

Chest x-ray

CT scan

MRI

PET scan

Thoracentesis: inserting needle, sample, remove fluid

Endoscopy: laryngoscopy, bronchoscopy, mediastinoscopy

Skin test

Blood test: arterial blood gasses (ABG’s), serology, CBC

Pulmonary function testing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Age related changes in the respiratory system

A
Decrease in elastic recoil of lungs
Loss of skeletal muscle strength in thorax/diaphragm
Fibrosis in alveoli
Fewer functional capillaries
Less effective cough
Decrease in pulmonary O2
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Patients with pneumonia

A

Pt with pneumonia
Leading cause of death due to infectious disease in the US
Highest incidence, mortality in older adults
Infectious or noninfectious
**causes by bacteria, viruses, fungal, other pathogens, aspiration of contents, inhalation of toxic material

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Patient with pneumonia | Infectiuous classifications
``` Community acquired: Streptococcus pneumonia (most common) Mycoplasma pneumonia Haemophilus pneumonia Influenzae Chlamydia pneumonia Influenza virus ``` ``` Nosocomial (hospital acquired): Staphylococcus aureus Gram negative bacterial -Klebsiella pneumonia -Pseudomonas aeruginosa -E coli ``` Opportunistic: Pneumocystis
26
Physiology review of lower respiratory tract
Lower respiratory tract normally sterile Defense mechanisms: mucous membranes of nose (sneezing) reflex closure of epiglottis, bronchial tree cilia, mucus lining respiratory tract (coughing) Aging impairs immune responses
27
Define pneumonia
Pneumonia: The inflammatory response causes fluid to accumulate in the alveoli and edema to form as alveolar capillaries dilate and allow fluid to leak into interstitial tissues
28
Pneumonia develops | Four patterns
Four patterns: Lobar pneumonia- involves the entire lobe of lung Bronchopneumonia- fluid tends to remain in the bronchia's and bronchi with less congestion in the alveoli Interstitial pneumonia- found in the interstitial tissue Miliary pneumonia- primarily seen in pts who are immunocompromised, typically enters through blood stream
29
Acute bacterial pneumonia
Acute bacterial pneumonia (quick onset): Respiratory: cough productive of rust colored or purulent sputum - Chest aching or pleuritic pain when coughing/breathing - Limited breathing sounds, fine crackles, rales heard over affected area of lung - Pleural friction rub may be audible - Systemic: shaking chills (rigor), fever Bronchopneumonia (slower onset): -Insidious onset, low grade fever, cough, scattered crackles Atypical presentation (older adults): fever, tachypnea, altered mental status, agitation, slight cough, minimal distress
30
Complications of Acute Bacterial Pneumonia
Typically infection resolves uneventfully Pleuritis is most common complication Lung abscess (relatively uncommon): -Most common etiology -Aspiration, resultant pneumonia -At-risk population Empyema- accumulation of purulent exudate in the pleural cavity.
31
Manifestations of Infectious Pneumonias Pneumococcal or lobar pneumonia Onset? Respiratory manifestations? Systemic manifestations?
Pneumococcal or lobar pneumonia Onset? abrupt Respiratory manifestations? Cough productive of purulent or rust-colored sputum; pleuritic or aching chest pain; decreased breath sounds and crackles over affected area; possible dyspnea and cyanosis Systemic manifestations? Chills and fever
32
Manifestations of Infectious Pneumonias Bronchopneumonia Onset? Respiratory manifestations? Systemic manifestations?
Bronchopneumonia Onset? gradual Respiratory manifestations? Cough, scattered crackles; minimal dyspnea and respiratory distress Systemic manifestations? Low-grade fever
33
Manifestations of Infectious Pneumonias Legionnaire disease Onset? Respiratory manifestations? Systemic manifestations?
Legionnaire disease Onset? gradual Respiratory manifestations? Dry cough; dyspnea Systemic manifestations? Chills and fever; general malaise; headache; confusion; anorexia and diarrhea; myalgias (muscle pain) and arthralgias (joint pain)
34
Manifestations of Infectious Pneumonias Primary atypical pneumonia Onset? Respiratory manifestations? Systemic manifestations?
Primary atypical pneumonia Onset? gradual Respiratory manifestations? Dry, hacking, nonproductive cough Systemic manifestations? Fever, headache, myalgias, and arthralgias dominate
35
Manifestations of Infectious Pneumonias Viral pneumonia Onset? Respiratory manifestations? Systemic manifestations?
Viral pneumonia Onset? sudden or gradual Respiratory manifestations? Dry cough Systemic manifestations? Flulike symptoms
36
Manifestations of Infectious Pneumonias Pneumocystis pneumonia Onset? Respiratory manifestations? Systemic manifestations?
Pneumocystis pneumonia Onset? abrupt Respiratory manifestations? Dry cough; tachypnea and shortness of breath; significant respiratory distress Systemic manifestations? Fever
37
Primary Atypical Pneumonia info, manifestations?
Mycoplasma pneumoniae College students and military recruits are primary affected population Primary atypical pneumonia is highly contagious Called “walking pneumonia” Mild respiratory manifestations Pharyngitis or bronchitis Dry, hacking, nonproductive cough ``` Systemic manifestations Fever Headache Myalgias Arthralgias ```
38
Viral Pneumonia info, manifestations
Mild disease Affects older adults, people with chronic conditions Cytomegalovirus (CMV) pneumonia is increasing in immunocompromised people. Occurs in community epidemics Influenza and adenovirus Respiratory Dry cough Systemic Flulike symptoms
39
Pneumocystis Pneumonia info, manifestation
AIDS and other immunocompromised patients Pneumocystis jiroveci Produces patchy involvement throughout the lungs Alveoli thicken, swell, and fill with fluid ``` Abrupt onset of symptoms: Fever Tachypnea Shortness of Breath Nonproductive cough ```
40
Manifestations of Pneumocystis Pneumonia
``` Tachypnea, SOB Dry, nonproductive cough Intercostal retractions Cyanosis Fever ```
41
Aspiration Pneumonia, risk factors, complications
Risk Factors: Emergency Surgery or Obstetric Procedure, depressed cough reflexes, impaired swallowing, elderly surgical patients, nutrition via NG or Gastric tube, and decreased LOC Aspiration of gastric contents into lungs Low p H of gastric contents causes inflammation Pulmonary edema/respiratory failure can result Complications: abscesses bronchiectasis gangrene of pulmonary tissue
42
Interprofessional Care of the Patient with Pneumonia-Diagnosis, tests
``` Chest x-ray Sputum gram stain Sputum C&S CBC, WBC w/ dif Serology when blood and sputum tests are negative Pulse ox, continuously ABG's Fiberoptic bronchoscopy ```
43
Interprofessional Care of the Patient with Pneumonia-Medications
Agents that "break up" mucus Acetylcysteine Potassium iodide Guaifenesin ``` Broad spectrum antibiotic Macrolide Penicillin Second- or third-generation cephalosporin Fluoroquinolone ``` Bronchodilators Sympathomimetic drugs Methylxanthines
44
Interprofessional Care of the Patient with Pneumonia-Treatment and Prevention
Immunization Pneumococcal vaccine -Pneumococcal Conjugate (PCV13, Prevnar), common used in children -Pneumococcal Polysaccharide (PPSV23, Pneumovax), given to adults, lifetime one dose. Influenza vaccine ``` Treatments Oxygen therapy -For patients who are tachypneic, hypoxemic -Low- or high-flow systems Chest physiotherapy -Percussion -Vibration -Postural drainage ```
45
Nursing Care of the Patient with Pneumonia
Diagnoses, outcomes, and interventions - Ineffective Airway Clearance - Ineffective Breathing Pattern - Activity Intolerance Continuity of care Usually treated in the community unless their respiratory status is significantly compromised or risk factors -Advanced age -Coexisting heart, kidney, or liver disease are present
46
The Patient with Tuberculosis
Chronic, recurrent infectious disease usually affecting the lungs Mycobacterium tuberculosis: Relatively slow-growing, acid-fast organism with a waxy outer capsule Airborne transmission by droplet nuclei: Suspended in air for hours
47
Epidemiology of Tuberculosis
Incidence and prevalence United States - Incidence fell until the mid-1980s - Resurgence late 1980s and early 1990s - Link to H I V/AIDS - Incidence is now declining Worldwide - Continues to be a significant health problem - An estimated 2 million deaths each year
48
Risk Factors for Tuberculosis
Characteristics of infected person Extent of air contamination Duration of exposure Susceptibility of host: Those in lower socioeconomic groups, injection drug users, the homeless, and people with alcoholism or H I V infection
49
Manifestations and Complications of Tuberculosis
``` Fatigue Weight loss Anorexia Low-grade afternoon fever Dry cough Night sweats Tuberculosis empyema Bronchopleural fistula ```
50
Interprofessional Care of the Patient with Tuberculosis
``` Early detection Accurate diagnosis Effective disease treatment Preventing spread to others Screening -Methods of tuberculin testing -Intradermal P P D (mantoux) test -Multiple-puncture (tine) testing ```
51
TB testing
Intradermal injection for tuberculin testing. The injection causes a local inflammatory response (wheal). Measurement of induration following tuberculin testing. The PPD will be administered intradermally on the dorsal aspect of the forearm , causing a wheel to develop approximately 6-10mm in diameter. the patient will have to return to the clinic after 48 to 72 hours to have the test read. The health care professional will measure the diameter of the induration.
52
Interpretation of Tuberculin Test
Less than 5 millimeter: Negative response, does not rule out infection 5-9 millimeter: Positive for people who are in close contact with someone with T B, are immunocompromised, have an organ transplant 10-15 millimeter: Positive for people who have other risk factors Greater than 15 millimeter: Positive for all people
53
TB Diagnosis
A positive tuberculin test alone does not indicate active disease Sputum smear is microscopically examined for acid-fast bacilli Positive sputum culture is definitive Sensitivity testing to determine appropriate drug therapy Polymerase chain reaction (P C R)-rapid detection of M. tuberculosis D N A Chest x-ray Liver function tests
54
TB Medication
Single-drug therapy: Isoniazid (I N H) Bacillus Calmette-Guerin (B C G) vaccination ``` Not widely used in the United States Two-or-more-drugs therapy: Isoniazid Rifampin Pyrazinamide Ethambutol Streptomycin ``` If a drug-resistant strain of T B: Therapy tailored to that resistance
55
TB Nursing Care
Health promotion -Risk to public health Awareness of TB as reemerging threat Early diagnosis and appropriate treatment is best for prevention Focus on infection control and ensuring compliance with prescribed treatment Diagnoses, outcomes, and interventions - Deficient Knowledge - Ineffective Therapeutic Regimen Management - Risk for Infection
56
The Patient with a Fungal Infection
Spores are present in the air that everyone breathes. Normal respiratory and immune defenses prevent infection in most people. Risk factors -Inadequate immune system
57
Pathophysiology of Fungal Infection
Histoplasmosis - Most common fungal infection in US - Found in soil and linked to bird and bat droppings - Histoplasma capsulatum - Most infections develop into latent asymptomatic disease - Primary acute histoplasmosis: Mild, self-limiting influenza type illness - Chronic progressive disease: Older adults in lungs but can involve other organs Disseminated histoplasmosis - Oftentimes fatal - Fever - Dyspnea - Cough - Weight Loss - Ulcerations of mouth and oropharynx - Muscle Wasting - Hepatomegaly - Splenomegaly
58
Aspergillosis
Spores are common in the environment; rarely cause disease except in the immunocompromised Invade blood vessels and produce hyphae that can cause thrombosis Manifestations - Dyspnea - Nonproductive cough - Pleuritic chest pain - Chills, fever - Hemoptysis or massive pulmonary hemorrhage can occur if the organism invades a pulmonary blood vessel
59
Diagnosis and Treatment of Fungal Infections | Diagnosis
``` Diagnosis Microscopic examination of sputum specimen Blood cultures Cerebrospinal fluid cultures Chest x-ray ```
60
Diagnosis and Treatment of Fungal Infections | Treatments
``` Treatments Oral itraconazole (Sporanox), a broad-spectrum antifungal agent, is commonly prescribed to treat histoplasmosis ``` Intravenous amphotericin B surgery (lobectomy)
61
Nursing Care of the Patient with a Fungal Infection
Education -Geographical locations and risk factors (exposure to bird droppings) Antifungal drugs -Teach about drug and interactions Pregnancy and birth control -Itraconazole is contraindicated during pregnancy and lactation. Monitor carefully during infusion and therapy -Amphotericin B is toxic must be monitored closely
62
The Patient with Obstructive Sleep Apnea | what is it?
Obstructive and Central Sleep Apnea Obstructive Sleep Apnea: Respiratory drive remains intact but airflow ceases due to occlusion of airway (most common type) Central sleep apnea rare: Caused by a neurological disorder
63
The Patient with Obstructive Sleep Apnea | Pathophysiology
Pathophysiology - Loss of normal pharyngeal muscle tone - Pharynx collapses during inspiration & tongue pulls against post. pharyngeal wall - Obstruction causes O2 sat, P O2, and p H to fall, P C O2 to rise -Asphyxia causes brief arousal from sleep Restores airway patency and airflow Episodes can occur hundreds of times a night
64
Manifestations of Obstructive Sleep Apnea
``` Loud, cyclic snoring, and restless sleep Excessive daytime sleepiness Irritability Gasping or choking during sleep Morning headache ``` Later Manifestations: Depression, intellectual impairment, and impotence Hypertension
65
Complications of Obstructive Sleep Apnea Factors
``` Complications Sleep fragmentation Loss of slow-wave sleep Dysrhythmias Sudden cardiac death Pulmonary hypertension Common in those who are morbidly obese ```
66
Obstructive Sleep Apnea and Risk Factors
``` Risk Factors Male gender Increasing age Obesity Large neck circumference Use of alcohol and C N S depressants ```
67
Diagnosis of Sleep Apnea
Overnight sleep study - Electroencephalogram - Measurements of ocular activity and muscle tone - Ventilatory activity and airflow - Continuous arterial oxygen saturation - Heart rate - Transcutaneous arterial P C O2
68
Treatment of Sleep Apnea
Mild-to-moderate apnea - Weight reduction - Abstaining from alcohol - Improving nasal patency - Avoiding supine sleeping position - Nasal continuous positive airway pressure (C P A P) is the treatment of choice for sleep apnea - Bi P A P ventilator provides less resistance to exhaling
69
Surgical Intervention for Sleep Apnea
Tonsillectomy Adenoidectomy Uvulopalatopharyngoplasty (U P P P) Tracheostomy
70
Nursing Care of the Patient with Sleep Apnea
Obstructive sleep apnea is often treated in the home Education of patient and family - Equipment use - Strategies to decrease contributing factors - Diagnoses, outcomes, and interventions - Disturbed Sleep Pattern - Fatigue - Ineffective Breathing Pattern - Impaired Gas Exchange - Risk for Injury - Risk for Sexual Dysfunction
71
The Patient with Lung Cancer info
- Leading cause of cancer deaths in United States - Accounts for 25% of all cancer deaths - Most people with lung cancer die within 1 year of initial diagnosis
72
Pathophysiology of Lung Cancer
Vast majority of primary lung lesions are bronchogenic carcinomas. -Bronchogenic carcinoma further differentiated by cell type Small-cell carcinomas -15% of lung cancers Non-small-cell carcinomas (adenocarcinoma, squamous cell carcinoma, and large cell carcinoma) -85% of lung cancers Spread via lymph system to other organs
73
Types of Lung Cancer | Small-cell (oat cell) carcinoma
Small-cell (oat cell) carcinoma, 15% of all lung cancers - Central mass - Aggressive tumor
74
Types of Lung Cancer | Adenocarcinoma
Adenocarcinoma, 20-40% of all lung cancers - Peripheral mass - Early metastasis
75
Types of Lung Cancer | Squamous cell
Squamous cell, 25-30% of all lung cancers | -Central mass in large bronchi
76
Types of Lung Cancer | Large cell carcinoma
Large cell carcinoma, 10-15% of all lung cancers | -Peripheral mass larger than adenocarcinoma
77
Incidence and Risk Factors of Lung Cancer
Populations at risk - Exposure to tobacco smoke - Age over 50 - Exposure to ionizing radiation and inhaled irritants - Exposure to radon
78
Manifestations of Lung Cancer
``` Chronic cough Hemoptysis Wheezing SOB Dull, aching chest pain or pleuritic pain Hoarseness and/or dysphagia Weight loss, anorexia Fatigue, weakness Bone pain Clubbing of fingers/toes ```
79
Complications and Course of Lung Cancer
Superior vena cava syndrome -Partial or complete obstruction of superior vena cava Paraneoplastic syndromes -Syndrome of inappropriate ADH secretion (SIADH), hyponatremia, edema, Cushing Syndrome, hypercalcemia, venous thrombosis or pulmonary embolism.
80
Diagnosis of Lung Cancer
``` Chest x-ray Sputum specimen Bronchoscopy C T scan Cytologic examination, biopsy C B C, liver function, serum electrolytes Tuberculin test Pulmonary function tests, A B G s ```
81
Treatment of Lung Cancer
Medications - Combination chemotherapy treatment of choice for small-cell lung cancer - Bronchodilators Surgery - Only real chance for cure in non-small cell lung cancers - Most tumors inoperable Radiation therapy - Used alone or in combination with surgery or chemotherapy - Either curative or palliative - “Debulks” tumors prior to surgery - Relieve manifestations, complications - External beam, intraluminal radiation, brachytherapy
82
Nursing Care of the Patient with Lung Cancer
Diagnoses, outcomes, and interventions Ineffective Breathing Pattern Assess respiratory status and oxygenation, pain, elevate HOB, Incentive Spirometer, Cough and Deep Breathe, Suction, Chest Physiotherapy. Activity Intolerance Assess physiologic responses to activity, plan rest periods between activities, increase activities gradually, teach energy conserving measures, keep frequently used objects within reach, administer O2 as prescribed, encourage physical activity Pain Assess pain, PRN pain meds for comfort or “around the clock” schedule for cancer pain, distraction, massage, positioning, and relaxation techniques. Anticipatory Grieving Spend time with patient/family, encourage expression of feelings/concerns, assist in grieving process, identify healthy coping measures, and encourage use of support systems
83
The Patient with a Laryngeal Tumor
Benign or malignant - Benign: Papillomas, Nodules, Polyps - Malignant: Squamous Cell Carcinoma most common Chronic shouting, projecting, or vocalizing Cigarette smoking and chronic irritation from industrial pollutants
84
Pathophysiology and Manifestations of Laryngeal Tumors part 1 or 2
Laryngeal -Most common malignancy is squamous-cell carcinoma -Leukoplakia White, patchy, and precancerous lesions on tongue/mouth -Erythroplakia Red, velvety patches thought to represent a later stage - Initial cancerous lesion, carcinoma in situ (CIS), will develop into squamous-cell cancer if untreated - Laryngeal cancer can develop in glottis, supraglottis, and subglottis
85
Pathophysiology and Manifestations of Laryngeal Tumors | part 2 of 2
Pathophysiology and manifestations Laryngeal cancer - Cancers of the vocal cords or glottis tend to be well-differentiated, slow-growing - Metastasis occurs late in illness - Manifestations Hoarseness: Change in voice quality - Cancer of supraglottis (epiglottis, aryepiglottic folds, arytenoid muscles, cartilage, and false vocal cords): Invades locally, metastasizes early - Subglottic tumors (below vocal cords): Often asymptomatic until enlarging tumor obstructs airway
86
Risk Factors for Laryngeal Tumors
``` Tobacco Alcohol Poor nutrition Human papillomavirus infection Exposure to asbestos Race: More common in African Americans ```
87
Interprofessional Care of the Patient with a Laryngeal Tumor
Benign tumors may resolve with correction of underlying issue Early detection of malignant tumors is critical to survival Diagnosis - Direct or indirect laryngoscopy when cancer is suspected - Biopsy - C T scan, MRI, chest x-ray, & PET
88
Treatment of Laryngeal Tumors
Benign vocal cord polyps - Inhaled steroid spray - Some cases call for surgery ``` Radiation therapy -Treatment of choice -Preserves voice -Chemoradiotherapy Chemotherapy ``` - Treats distant metastasis - Palliation when tumor unresectable - Cisplatin and 5-fluorouracil
89
Surgical Intervention for Laryngeal Tumors
Goals - Remove the malignancy - Maintain airway patency - Achieve optimal cosmetic appearance ``` Laser laryngoscopy (carcinoma in situ, vocal cord polyps, & early vocal cord cancers) ``` Laryngectomy - Partial laryngectomy - ---Hemilaryngectomy - ---Vertical partial laryngectomy - Total Radical neck dissection Modified neck dissection
90
total laryngectomy
Following a total laryngectomy, the patient has a permanent tracheostomy. No connection between the trachea and esophagus remains.
91
tracheoesophageal prosthesis (T E P)
The tracheoesophageal prosthesis (T E P) allows diversion of air from the trachea through a one-way valve into the esophagus and oropharynx, producing speech when the tracheostomy stoma is occluded. The one-way valve prevents food from entering the trachea.
92
Post-Surgical Care for the Patient with a Laryngeal Tumor
Speech rehabilitation Necessary if entire larynx is removed Techniques - Tracheoesophageal puncture (TEP) with placement of a one-way shunt valve - Esophageal speech - Use of speech generators
93
Nursing Care of the Patient with a Laryngeal Tumor
Emphasize the need for patients with chronic hoarseness to seek treatment Health promotion Prevent tobacco use in children, adolescents, and young adults Discourage use of alcohol
94
Nursing Care of the Patient with a Laryngeal Tumor | Diagnoses, outcomes, and interventions
Diagnoses, outcomes, and interventions - Risk for Impaired Airway Clearance - Impaired Verbal Communication - Impaired Swallowing - Imbalanced Nutrition: Less Than Body Requirements - Anticipatory Grieving
95
The Patient with Asthma | what is it?
Asthma - Chronic inflammatory disorder of airways - Recurrent episodes of wheezing, breathlessness, chest tightness, coughing Rare acute cases can be severe enough to cause respiratory failure, death
96
Pathophysiology of Asthma Chronic Subacute Acute
Chronic inflammatory disorder of airways Subacute state - Inflammation quiet - Inflammatory cells present in airway tissues Acute episodes - Widespread airflow obstruction - Antigen-antibody response - Inflammatory mediators released - Bronchoconstriction, airway edema, impaired mucociliar clearance
97
Triggers for Asthma
``` Allergens Chemical agents in the workplace Respiratory infections Exercise Emotional stress Pharmacologic -N S A I D s, beta-blockers, sulfites ```
98
Responses to Asthma Acute or early response Late phase response
Acute or early response - Inflammatory mediators - Activation of inflammatory cells - Stimulation of parasympathetic receptors - Bronchoconstriction and impaired gas exchange Late phase response -4-12 hours after trigger
99
Manifestations and Complications
``` Wheezing Breathlessness Chest tightness Coughing Dyspnea Status asthmaticus -Severe, prolonged asthma -Does not respond to treatment ```
100
Diagnosis of Asthma
``` History and manifestations Pulmonary function tests (P F T s) Challenge or bronchial provocation tests A B G s Skin tests ```
101
Interprofessional Care of the Patient with Asthma
Disease monitoring - Peak expiratory flow rate (P E F R) - Evaluated by traffic signals Preventative measures - Avoiding allergens, environmental triggers - Eliminating tobacco - Early treatment of respiratory infections
102
Medications for asthma
Long-term control - Anti-inflammatory agents - Long-acting bronchodilators - Leukotriene modifiers Quick relief - Short-acting adrenergic stimulants - Anticholinergic drugs - Methylxanthines Routes of administration - Metered-dose inhaler (M D I) - Dry powder inhaler (D P I) - Nebulizer Bronchodilators -Adrenergic stimulants, anticholinergic agents, and methylxanthines In combination with anti-inflammatory Anti-inflammatory agents - Corticosteroids - Cromolyn sodium and nedocromil Leukotriene modifiers - Montelukast, zafirlukast, zileuton - Reduce need for short-acting bronchodilators
103
Nursing Care of the Patient with Asthma
Health promotion - Link between smoking, childhood asthma - Smoking cessation
104
Nursing Care of the Patient with Asthma | Diagnoses, outcomes, and interventions
Diagnoses, outcomes, and interventions - Ineffective Airway Clearance- monitor LOC, assess pulse oximetry, assess cough effort and sputum, raise HOB, administer O2 and nebulizer Tx as ordered - Ineffective Breathing Pattern-Assess RR, pattern and breath sounds, vital signs, labs, assist with ADL’s, provide rest between scheduled activities, teach pursed lip breathing and relaxation techniques, Administer O2 and bronchodilators/anti-inflammatories as ordered. - Anxiety-Assess level of anxiety, identify coping skills, provide physical and emotional support, active listening, provide clear instructions, reduce excessive environmental stimuli, relaxation techniques. - Ineffective Therapeutic Regimen Management-Assess level of understanding about treatment and diagnosis, discuss perceptions of illness, identify problems integrating tx plan into lifestyle, provide verbal and written instructions
105
The Patient with Chronic Obstructive Pulmonary Disease
Also known as C O P D Pathophysiology -Chronic bronchitis and/or emphysema -Characterized by slow progressive obstruction of airways: Resistance to airflow increases Expiration becomes slow or difficult Mismatch between alveolar ventilation and perfusion Impaired gas exchange
106
Pathophysiology of COPD | Chronic bronchitis
Chronic bronchitis - Inhaled irritants cause chronic inflammation - Production of thick mucus - Productive cough lasting 3 or more months in 2 consecutive years - Narrowing of airways - Common recurrent infection
107
Pathophysiology of COPD | Emphysema
Emphysema - Destruction of the walls of the alveoli - Enlargement of abnormal air spaces - Airway collapse - Loss of alveolar surface area for gas exchange
108
Manifestations of COPD
COPD is classified according to severity, staged from 0 to 4 Productive cough, often in mornings Dyspnea with activity, exercise intolerance Presence of a barrel-shaped chest
109
Incidence and Risk Factors of C O P D
``` Fourth leading cause of death in U.S Cigarette smoking Air pollution Occupational exposures Airway infection Familial and genetic factors ```
110
Diagnosis of COPD
``` Pulmonary function tests Ventilation-perfusion scanning Serum alpha1-antitrypsin levels A B G s Pulse oximetry C B C with W B C differential Chest x-ray ```
111
Medications for C O P D
- Immunizations against pneumococcal pneumonia and influenza - Broad-spectrum antibiotics for suspected infection - Bronchodilators- improves airflow and reduce air trapping - Corticosteroids when asthma is component - Alpha1-antitrypsin replacement therapy for those with genetic deficiency
112
Treatments for C O P D
``` Smoking cessation Avoidance of airway irritants and allergens Pulmonary hygiene measures Adequate hydration Pulmonary rehabilitation (P R) Pursed Lip Breathing Regular aerobic exercise, if applicable Oxygen -Long-term oxygen therapy Surgery -Lung transplant -Lung reduction surgery ```
113
Nursing Care of the Patient with C O P D | Diagnoses, outcomes, and interventions
Diagnoses, outcomes, and interventions - Ineffective Airway Clearance- assess respiratory status, rate, cough, secretions, oxygen saturation, I/O, mucous membranes, encourage fluid intake of 2500ml/day, elevate HOB, coughing/deep breathing, suction, provide rest periods, oxygen, expectorants/bronchodilators. - Imbalanced Nutrition: Less Than Body Requirements- assess nutritional status, monitor food intake, provide frequent, small feedings, elevate HOB for meals, provide snacks at bedside, assist with choosing preferred foods, and consult with dietician. - Compromised Family Coping- Assess family interactions and effects of illness on them, identify coping strengths/weaknesses, provide teaching on COPD, encourage expression of feelings and avoid judgment, encourage family participation in care, family care conferences. - Decisional Conflict: Smoking- Assess knowledge and understanding, acknowledge concerns and beliefs, listen nonjudgmentally, encourage expression of feelings, assist with creating plan to quit, provide referrals to outside support personal or groups.